Antonella Dal Mas

Platelet Concentration in Platelet-Rich Plasma Affects Tenocyte Behavior<i>In Vitro</i>

Ilaria Giusti, Sandra D’Ascenzo, A Manco et al. · BioMed Research International · 2014 · 97 citations · Full text

Prognostic value of KRAS genotype in metastatic colorectal cancer (MCRC) patients treated with intensive triplet chemotherapy plus bevacizumab (FIr-B/FOx) according to extension of metastatic disease

Gemma Bruera, Katia Cannita, Daniela Di Giacomo et al. · BMC Medicine · 2012 · 23 citations · Full text

<i>KRAS</i>, <i>NRAS</i> and <i>BRAF</i> mutations detected by next generation sequencing, and differential clinical outcome in metastatic colorectal cancer (MCRC) patients treated with first line FIr-B/FOx adding bevacizumab (BEV) to triplet chemotherapy

Gemma Bruera, Francesco Pepe, Umberto Malapelle et al. · Oncotarget · 2018 · 19 citations · Full text

Anthracycline-Free Neoadjuvant Treatment in Patients with HER2-Positive Breast Cancer: Real-Life Use of Pertuzumab, Trastuzumab and Taxanes Association with an Exploratory Analysis of PIK3CA Mutational Status

Azzurra Irelli, Alessandro Parisi, C. D’Orazio et al. · Cancers · 2022 · 11 citations · Full text